Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 3.30
STAA's Cash to Debt is ranked higher than
76% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. STAA: 3.30 )
STAA' s 10-Year Cash to Debt Range
Min: 0.08   Max: 9.66
Current: 3.3

0.08
9.66
Equity to Asset 0.65
STAA's Equity to Asset is ranked higher than
74% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. STAA: 0.65 )
STAA' s 10-Year Equity to Asset Range
Min: 0.29   Max: 0.81
Current: 0.65

0.29
0.81
Interest Coverage 4.12
STAA's Interest Coverage is ranked higher than
51% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.42 vs. STAA: 4.12 )
STAA' s 10-Year Interest Coverage Range
Min: 4.12   Max: 27.5
Current: 4.12

4.12
27.5
F-Score: 2
Z-Score: 8.26
M-Score: -2.48
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -7.16
STAA's Operating margin (%) is ranked higher than
60% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. STAA: -7.16 )
STAA' s 10-Year Operating margin (%) Range
Min: -37.38   Max: 23.93
Current: -7.16

-37.38
23.93
Net-margin (%) -8.70
STAA's Net-margin (%) is ranked higher than
60% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.97 vs. STAA: -8.70 )
STAA' s 10-Year Net-margin (%) Range
Min: -35.56   Max: 30.29
Current: -8.7

-35.56
30.29
ROE (%) -16.79
STAA's ROE (%) is ranked higher than
57% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.15 vs. STAA: -16.79 )
STAA' s 10-Year ROE (%) Range
Min: -88.78   Max: 29.59
Current: -16.79

-88.78
29.59
ROA (%) -10.75
STAA's ROA (%) is ranked higher than
57% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. STAA: -10.75 )
STAA' s 10-Year ROA (%) Range
Min: -43.45   Max: 22.16
Current: -10.75

-43.45
22.16
ROC (Joel Greenblatt) (%) -22.29
STAA's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. STAA: -22.29 )
STAA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -130.04   Max: 62.01
Current: -22.29

-130.04
62.01
Revenue Growth (%) 5.80
STAA's Revenue Growth (%) is ranked higher than
76% of the 261 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. STAA: 5.80 )
STAA' s 10-Year Revenue Growth (%) Range
Min: -12.5   Max: 14.8
Current: 5.8

-12.5
14.8
» STAA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

STAA Guru Trades in Q4 2013

Chuck Royce 233,276 sh (New)
Jim Simons 32,100 sh (-61.73%)
» More
Q1 2014

STAA Guru Trades in Q1 2014

Chuck Royce 233,276 sh (unchged)
Jim Simons 31,600 sh (-1.56%)
» More
Q2 2014

STAA Guru Trades in Q2 2014

Steven Cohen 109,500 sh (unchged)
Chuck Royce 233,276 sh (unchged)
Jim Simons Sold Out
» More
Q3 2014

STAA Guru Trades in Q3 2014

Chuck Royce 233,276 sh (unchged)
Steven Cohen 31,500 sh (-71.23%)
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 8.70
STAA's P/B is ranked higher than
56% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. STAA: 8.70 )
STAA' s 10-Year P/B Range
Min: 1.38   Max: 17.54
Current: 8.7

1.38
17.54
P/S 4.50
STAA's P/S is ranked higher than
61% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. STAA: 4.50 )
STAA' s 10-Year P/S Range
Min: 0.31   Max: 9.81
Current: 4.5

0.31
9.81
EV-to-EBIT -62.82
STAA's EV-to-EBIT is ranked lower than
58% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.27 vs. STAA: -62.82 )
STAA' s 10-Year EV-to-EBIT Range
Min: -580.6   Max: 902
Current: -62.82

-580.6
902
Current Ratio 2.91
STAA's Current Ratio is ranked higher than
75% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. STAA: 2.91 )
STAA' s 10-Year Current Ratio Range
Min: 1.06   Max: 3.77
Current: 2.91

1.06
3.77
Quick Ratio 1.98
STAA's Quick Ratio is ranked higher than
72% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. STAA: 1.98 )
STAA' s 10-Year Quick Ratio Range
Min: 0.55   Max: 2.37
Current: 1.98

0.55
2.37

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 28.30
STAA's Price/Net Current Asset Value is ranked higher than
81% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. STAA: 28.30 )
STAA' s 10-Year Price/Net Current Asset Value Range
Min: 6.04   Max: 1731.3
Current: 28.3

6.04
1731.3
Price/Tangible Book 9.43
STAA's Price/Tangible Book is ranked higher than
64% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.41 vs. STAA: 9.43 )
STAA' s 10-Year Price/Tangible Book Range
Min: 0.94   Max: 23.8
Current: 9.43

0.94
23.8
Price/DCF (Projected) 17.97
STAA's Price/DCF (Projected) is ranked higher than
72% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. STAA: 17.97 )
STAA' s 10-Year Price/DCF (Projected) Range
Min: 0.87   Max: 128.14
Current: 17.97

0.87
128.14
Price/Median PS Value 1.60
STAA's Price/Median PS Value is ranked higher than
60% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. STAA: 1.60 )
STAA' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 3.37
Current: 1.6

0.14
3.37
Earnings Yield (Greenblatt) -1.60
STAA's Earnings Yield (Greenblatt) is ranked higher than
60% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. STAA: -1.60 )
STAA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.9
Current: -1.6

0.1
0.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:SR3.Germany
STAAR Surgical was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used in corrective surgery, and it also makes lenses for use in surgery that treats cataracts. All of the lenses it make are foldable, which permits the surgeon to insert them through a small incision during minimally invasive surgery. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company operates its administrative headquarters and a manufacturing facility in Monrovia, California. The Monrovia manufacturing facility principally makes Collamer and silicone IOLs and injector systems for IOLs and ICLs. The Company also currently manufactures the raw material for Collamer lenses (both IOLs and ICLs) and the AquaFlow Device (for the treatment of glaucoma) in a facility in Aliso Viejo, California. It operates an administrative, manufacturing and distribution facility in Nidau, Switzerland under its wholly owned subsidiary, STAAR Surgical AG. The Nidau manufacturing facility makes all of STAAR's Visian ICL products and also manufactures the AquaFlow Device. It operates administrative, manufacturing and distribution facilities in Japan under its wholly owned subsidiary, STAAR Japan Inc. STAAR Japan's administrative facility is located in Shin-Urayasu and its manufacturing and distribution facility is located in Ichikawa City. STAAR currently assembles all of its preloaded IOL injectors at the Ichikawa City facility. The Company competes with Novartis, Abbott and Valeant. The Company is subject to periodic inspection by the FDA for compliance with the FDA's quality system regulations and requirements, such as restrictions on advertising and promotion.
» More Articles for STAA

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 
STAAR Surgical Generates Cash From Operations During Second Quarter Aug 03 2009 

More From Other Websites
Nasdaq stocks posting largest percentage decreases Nov 28 2014
Faruqi & Faruqi, LLP is Investigating STAAR Surgical Company (STAA) on Behalf of its Shareholders Nov 26 2014
STAAR Surgical To Present At The 26th Annual Piper Jaffray Healthcare Investor Conference Nov 25 2014
STAAR Surgical To Present At The 26th Annual Piper Jaffray Healthcare Investor Conference Nov 25 2014
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 20 2014
STAAR Surgical To Present At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum Nov 17 2014
STAAR Surgical To Present At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum Nov 17 2014
STAAR SURGICAL CO Financials Nov 15 2014
10-Q for STAAR Surgical Co. Nov 10 2014
STAAR SURGICAL CO Files SEC form 10-Q, Quarterly Report Nov 07 2014
STAAR Surgical To Present At The Stephens 2014 Fall Investment Conference Nov 06 2014
STAAR Surgical To Present At The Stephens 2014 Fall Investment Conference Nov 06 2014
Staar Surgical (STAA) Downgraded From Hold to Sell Nov 05 2014
STAAR Surgical Gains Final Step in Regulatory Approval for Visian® ICL™ with CentraFLOW® in... Nov 04 2014
STAAR Surgical Gains Final Step in Regulatory Approval for Visian® ICL™ with CentraFLOW® in... Nov 04 2014
Staar Surgical posts 3Q loss Oct 30 2014
STAAR Surgical Co Earnings Call scheduled for 4:30 pm ET today Oct 30 2014
STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Oct 30 2014
STAAR Surgical Reports Third Quarter Results Oct 30 2014
Q3 2014 STAAR Surgical Co Earnings Release - After Market Close Oct 30 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK